Evidence map›Paper›PMID 29556231›Full record

ArticleFrontiers in immunology2018

C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance.

Rachel V Jimenez, Tyler T Wright, Nicholas R Jones, Jianming Wu, Andrew W Gibson, Alexander J Szalai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. C-reactive protein impairs immune response of CD8Journal for immunotherapy of cancer · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  16. Cell Trafficking at the Intersection of the Tumor-Immune Compartments.Annual review of biomedical engineering · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rachel V JimenezDepartment of Medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, United States.
Tyler T WrightDivision of Drug Development, Southern Research, Birmingham, AL, United States.
Nicholas R JonesDepartment of Medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, United States.
Jianming WuDepartment of Veterinary and Biomedical Sciences, University of Minnesota, Minneapolis, MN, United States.
Andrew W GibsonDepartment of Medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, United States.
Alexander J SzalaiDepartment of Medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, United States.
University of Alabama at Birmingham · USSouthern Research Institute · USUniversity of Minnesota · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Recessive PKD Research and Translational Core CenterP30DK074038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 2005 to 2019
$16.6M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB Diabetes Research and Training CenterP60DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 2008 to 2012
$8.4M
C-reactive protein in acute kidney injuryR01DK099092 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SZALAI, ALEXANDER J · 2014 to 2017
$1.3M
Impact of SLE-Associated ITGAM Variants on Dendritic Cell FunctionR21AR069295 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BULLARD, DANIEL C, SZALAI, ALEXANDER J · 2016 to 2017
$351k
C-reactive protein mediated signals in renal injury and repairF31DK112646 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JIMENEZ, RACHEL V · 2017 to 2019
$106k
C-reactive Protein, Autoimmunity, and Inflammation in the Central Nervous SystemF31NS081903 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WRIGHT, TYLER T · 2013 to 2015
$74k
NCI NIH HHS P30 CA013148NIAMS NIH HHS P30 AR048311NIAMS NIH HHS R21 AR069295NIDDK NIH HHS F31 DK112646NIDDK NIH HHS P30 DK074038NIDDK NIH HHS P60 DK079626NIDDK NIH HHS R01 DK099092NINDS NIH HHS F31 NS081903
6 · The paper itself

Abstract

C-reactive protein (CRP) is the prototypical acute phase reactant, increasing in blood concentration rapidly and several-fold in response to inflammation. Recent evidence indicates that CRP has an important physiological role even at low, baseline levels, or in the absence of overt inflammation. For example, we have shown that human CRP inhibits the progression of experimental autoimmune encephalomyelitis (EAE) in CRP transgenic mice by shifting CD4

Indexed as

Cell DifferentiationAnimalsCD11c AntigenCell ProliferationCells, CulturedC-Reactive ProteinDendritic CellsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalHumansLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMultiple SclerosisPeripheral ToleranceCD11c AntigenC-Reactive ProteinFCGR2B protein, humanReceptors, IgGacute phase responseagingautoimmunityinflammaginginflammationtransgenic

Identifiers

PMID29556231
PMCPMC5845098
OpenAlexW2789900897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.